[ RadSafe ] Radiobioassay and FDA Approval
Clayton J Bradt
CJB01 at health.state.ny.us
Fri Mar 2 10:17:03 CST 2012
Stan, what's the difference between "CLIA certification" and "FDA
approval"?
Clayton J. Bradt
Principal Radiophysicist
NYS Dept. of Health
Biggs Laboratory, Room D486A
Empire State Plaza
Albany, NY 12201-0509
518-474-1993
*********************
It is my personal opinion that the analysis of excreta material is only a
part of the dose-evaluation process. As long as the laboratory reporting
the analytical results does not provide a dose estimate, there is no
reason
to require FDA 'approval' should it exist. It should be understood that
the
laboratory be required to participate in the appropriate
performance-evaluation programs (i.e., DOELAP, NAVLAP, Oak Ridge, etc.)
that
determine ability to provide an acceptable result. I agree the laboratory
should be CLIA certified.
Most HP/MDs that provide dose estimates employ computer programs as part
of
the process, i.e. IMBA , DCAL, etc. I know of no program within the FDA
that has the ability to evaluate these codes, or do I know of a program
within FDA that can issue 'approval' to an analytical laboratory to
perform
radiobioassay work. In fact, I know of no program in any form that
evaluates the entire dosimetric assessment process. One can see a need.
Stan Morton
Manger, Radiobioassay Programs
GEL Laboratories
*******************
More information about the RadSafe
mailing list